XOMAP
Price:
$24.98
Market Cap:
$503.77M
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty...[Read more]
Industry
Biotechnology
IPO Date
2020-12-16
Stock Exchange
NASDAQ
Ticker
XOMAP
According to XOMA Royalty Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 13.72. This represents a change of -42.17% compared to the average of 23.73 of the last 4 quarters.
The mean historical PE Ratio of XOMA Royalty Corporation over the last ten years is 7.96. The current 13.72 PE Ratio has changed 17.13% with respect to the historical average. Over the past ten years (40 quarters), XOMAP's PE Ratio was at its highest in in the March 2025 quarter at 83.04. The PE Ratio was at its lowest in in the December 2017 quarter at -55.63.
Average
7.96
Median
-2.53
Minimum
-31.02
Maximum
53.82
Discovering the peaks and valleys of XOMA Royalty Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 289.93%
Maximum Annual PE Ratio = 53.82
Minimum Annual Increase = -10099.49%
Minimum Annual PE Ratio = -31.02
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 17.38 | -209.12% |
| 2024 | -15.93 | 247.82% |
| 2023 | -4.58 | -50.72% |
| 2022 | -9.29 | -130.75% |
| 2021 | 30.22 | -43.85% |
| 2020 | 53.82 | -273.48% |
| 2019 | -31.02 | 289.93% |
| 2018 | -7.96 | -116.76% |
| 2017 | 47.47 | -10099.49% |
| 2016 | -0.47 | -93.75% |
The current PE Ratio of XOMA Royalty Corporation (XOMAP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.04
5-year avg
3.56
10-year avg
7.96
XOMA Royalty Corporation’s PE Ratio is greater than Tectonic Therapeutic, Inc. (-5.78), greater than Aldeyra The (-3.50), greater than Amarin Corporation plc (-9.38), greater than AC Immune S.A. (-4.98), greater than Lyell Immunopharma, Inc. (-0.67), greater than Genelux Corporation (-2.85), greater than Silence Therapeutics plc (-3.23), greater than Cellectis S.A. (-2.32), greater than Larimar Therapeutics, Inc. (-1.92), greater than Kyverna Therapeutics, Inc. (-2.41),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.78 | $498.73M | |
| -3.50 | $81.69M | |
| -9.38 | $277.15M | |
| -4.98 | $266.14M | |
| -0.67 | $262.32M | |
| -2.85 | $113.89M | |
| -3.23 | $580.98M | |
| -2.32 | $153.64M | |
| -1.92 | $397.04M | |
| -2.41 | $431.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Royalty Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XOMA Royalty Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is XOMA Royalty Corporation's PE Ratio?
How is the PE Ratio calculated for XOMA Royalty Corporation (XOMAP)?
What is the highest PE Ratio for XOMA Royalty Corporation (XOMAP)?
What is the 3-year average PE Ratio for XOMA Royalty Corporation (XOMAP)?
What is the 5-year average PE Ratio for XOMA Royalty Corporation (XOMAP)?
How does the current PE Ratio for XOMA Royalty Corporation (XOMAP) compare to its historical average?